[CEA and TPA in bladder carcinoma].
Latella
G
G
Ciarniello
P
P
Fusco
A
A
Liberti
M
M
Gentile
V
V
De Berardinis
E
E
Von Heland
M
M
D000328:Adult; D000368:Aged; D000951:Antigens, Neoplasm / Q000032:analysis*; D002272:Carcinoembryonic Antigen / Q000032:analysis*; D002277:Carcinoma / Q000175:diagnosis* / Q000473:pathology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D010212:Papilloma / Q000175:diagnosis / Q000473:pathology; D010455:Peptides / Q000097:blood*; D019396:Tissue Polypeptide Antigen; D001749:Urinary Bladder Neoplasms / Q000175:diagnosis* / Q000473:pathology
D000951:Antigens, Neoplasm; D002272:Carcinoembryonic Antigen; D010455:Peptides; D019396:Tissue Polypeptide Antigen
CEA e TPA nel carcinoma della vescica.